Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial (ATEGE-LIVER)

This study has been terminated.
(Experimental arm (induction + low dose tacrolimus) not effective.)
Sponsor:
Collaborators:
Fresenius AG
Astellas Pharma Inc
Information provided by:
Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT00436722
First received: February 16, 2007
Last updated: May 19, 2009
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
No publications provided by Hospital Clinic of Barcelona

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):